Anthony King
I am a freelance science journalist based in Dublin, Ireland. I cover a variety of topics in chemical and biological sciences, as well as science policy, health and innovation.
My articles have appeared in Nature, Science, Cell, Chemistry World, New Scientist, the Irish Times, New York Times, EMBO Reports, Chemistry & Industry and more.
I enjoy writing on a wide breadth of subjects, from antibiotics to petrochemicals, bumblebees to asteroid composition, palaeontology to brain development. Previously I worked for a publishing company as a science editor.
My primary degree in science is from Trinity College Dublin and I hold a Master’s degree in science communications from Dublin City University.
BusinessAllergan sidesteps patent review with tribal deal
Native Americans agree to use sovereign immunity to protect intellectual property from double challenge
ResearchSingle mutation keeps lethal frog from poisoning itself
Poison dart frogs are resistant to neurotoxin because of modified sodium channel proteins
ResearchGut bugs hijacking our signalling could treat disease
Gastrointestinal microflora found to produce a profusion of molecules that can affect human health
FeatureEnvironmentally benign by design
The challenge of designing drugs with biodegradability in mind
NewsWhat's going on in your ice cream
All right, stop, collaborate and listen: ice cream’s back with a new explanation
NewsNew database offers one stop shop for food safety hazards
Tool brings together safety information from Europe’s food safety agency
BusinessReckitt Benckiser to buy into baby milk
$17bn acquisition of Mead Johnson expands presence in developing markets, especially China
ResearchFluorescent frog first down to new molecule
Blue–green glow of the polka-dot tree frogs may help them to ’chat’ with each other
BusinessEU conditionally approves Dow–DuPont merger
To satisfy competition concerns, DuPont will swap crop protection R&D assets for FMC’s nutrition business
FeatureSpinning out spider silk research
Spider silk is finding applications as diverse as tissue transplants and training shoes
News'Hard Brexit' threat to skilled workers
Migration model suggests scientists and other professionals will avoid the UK
NewsAction on white asbestos blocked by top exporters
Chrysotile will not be added to Rotterdam Convention’s list of hazardous substances
FeatureDelivering gene therapy
After some well-publicised problems, gene therapy – delivering DNA into people’s cells using viruses – is booming, Anthony King finds
ResearchGarden centre plants may pose pesticide threat to bees
Insecticides on ornamental UK plants found at levels known to have an impact on pollinators
NewsWhy asbestos is still used around the world
Unpicking the politics of a potentially deadly material
SponsoredControlling the temperature
We find out from Julabo how to keep cool (or hot) under pressure with Presto temperature control units
ResearchSticky solution for surgery takes inspiration from slug slime
Adhesive held strong on a beating rat heart and glued a liver back together
NewsAntibiotic partnership plans accelerated drug development
Public–private venture will invest $350 million over five years but there are warnings that much more money is still needed
NewsReport takes aim at research assessment’s cost and distortions
Head of British Academy recommends more flexibility for the Research Excellence Framework to end ‘gaming’ of the exercise
